This article has been updated from a version posted Feb. 22 to include comments from an OGT executive.
According to the study's findings, the major vendors' platforms performed well in terms of reproducibility, but Agilent's microarrays showed better linearity and dynamic range.
Using gene dosage, expression, and ontology data, the researchers identified recurrent changes linked to cervical cancer development and treatment outcomes.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The Associated Press reports that gene-edited food may soon be for sale.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.